Overview

GSK706769 Repeat Dose Study

Status:
Completed
Trial end date:
2008-09-12
Target enrollment:
Participant gender:
Summary
To determine safety, tolerability and Pharmacokinetics of GSK706769
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline